ESOU 2021: Neoadjuvant vs Adjuvant Chemotherapy/Immunotherapy in High-Risk UTUC: Indications and Controversies
(UroToday.com) The second Urothelial Cancer session at this year’s European Association of Urology (EAU) Section of Oncological Urology (ESOU) virtual annual meeting featured a number of presentations, focussing on controversies in the management of urothelial cancers. The first presentation in this session was from Dr. Andrea Necchi who discussed the indications and controversies surrounding the use […]